» Authors » Amy Bohnert

Amy Bohnert

Explore the profile of Amy Bohnert including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 45
Citations 832
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Becker W, Seal K, Nelson D, DeRonne B, Kats A, Morasco B, et al.
JAMA Intern Med . 2025 Feb; PMID: 39960730
Importance: Guidelines recommend dose reduction or discontinuation of long-term opioid therapy when harm outweighs benefit, but strategies to help patients do so are limited. Objective: To test optionally switching to...
2.
Ioannou G, Berry K, Rajeevan N, Li Y, Yan L, Huang Y, et al.
Ann Intern Med . 2025 Feb; PMID: 39903865
Background: Monovalent COVID-19 vaccines targeting the XBB.1.5 Omicron variant were introduced in September 2023. In the absence of randomized controlled trials demonstrating their efficacy, information on real-world vaccine effectiveness (VE)...
3.
Krebs E, Becker W, Nelson D, DeRonne B, Jensen A, Kats A, et al.
JAMA Intern Med . 2024 Dec; 185(2):208-220. PMID: 39652356
Importance: Patients prescribed long-term opioid therapy for chronic pain often experience unrelieved pain, poor quality of life, and serious adverse events. Objective: To compare the effects of integrated pain team...
4.
Kim E, Sinco B, Zhao J, Fang Y, Cunningham C, Frank E, et al.
JAMA Netw Open . 2024 Jun; 7(6):e2418082. PMID: 38904957
Importance: The implications of new-onset depressive symptoms during residency, particularly for first-year physicians (ie, interns), on the long-term mental health of physicians are unknown. Objective: To examine the association between...
5.
Jaffe K, Patel S, Chen L, Slat S, Bohnert A, Lagisetty P
Subst Use Addctn J . 2024 Jun; 45(4):706-715. PMID: 38828548
Background: Medications for opioid use disorders (MOUDs) are effective, but most people with opioid use disorder (OUD) do not receive treatment. Prior research has explored patients' structural barriers to access...
6.
Irani E, Macleod C, Slat S, Kehne A, Madden E, Jaffe K, et al.
Drug Alcohol Depend Rep . 2024 May; 11():100235. PMID: 38737490
Purpose: Negative perceptions around medications for opioid use disorder (MOUD) amongst the public could deter patients with opioid use disorder (OUD) from engaging with MOUD. Thus, we evaluated whether a...
7.
Viglianti E, Oliverio A, Meeks L, Bohnert A, Bell S
Trends Mol Med . 2024 May; 30(6):521-523. PMID: 38734573
Sexual harassment in academia is endemic driven by gender-based inequalities and sustained through organizational tolerance, and its impact extends beyond the primary victim(s). Applying principles of emergency management provides a...
8.
Jaffe K, Slat S, Chen L, Macleod C, Bohnert A, Lagisetty P
J Subst Use Addict Treat . 2024 May; 163:209361. PMID: 38703949
Introduction: Medications for opioid use disorder (MOUD) including methadone (MMT), buprenorphine (BUP), and naltrexone (NTX) are safe and effective. However, there are significant negative perceptions surrounding MOUD, creating barriers to...
9.
Merlin J, Black A, Midboe A, Troszak L, Asch S, Bohnert A, et al.
BMJ Oncol . 2024 Jan; 2(1). PMID: 38259328
Objective: Pain is experienced by most patients with cancer and opioids are a cornerstone of management. Our objectives were (1) to identify patterns or trajectories of long-term opioid therapy (LTOT)...
10.
Ioannou G, Berry K, Rajeevan N, Li Y, Mutalik P, Yan L, et al.
Ann Intern Med . 2023 Oct; 176(11):1486-1497. PMID: 37903369
Background: COVID-19 has been linked to the development of many post-COVID-19 conditions (PCCs) after acute infection. Limited information is available on the effectiveness of oral antivirals used to treat acute...